FDA Requires Labeling Change for Some Drugs Used to Prevent Rejection of Kidney Transplants

["U.S. Food & Drug Administration (FDA)" <fda@xxxxxxxxxxxxxxxxxxxxxxx>]

Title: FDA Requires Labeling Change for Some Drugs Used to Prevent Rejection of Kidney Transplants

FDA Requires Labeling Change for Some Drugs Used to Prevent Rejection of Kidney Transplants
Tue, 14 Jul 2009 09:28:00 -0500

The U.S. Food and Drug Administration today said that it will require manufacturers of some immunosuppressant drugs used in kidney (renal) transplantation to update their labeling to reflect an increased risk of infections.

---

Manage your FDA Subscriptions:

• Update your preferences or unsubscribe
• Questions about this service? support@xxxxxxxxxxxxxxx
• Other inquiries? webmail@xxxxxxxxxx

GovDelivery, Inc. sending on behalf of U.S. Food & Drug Administration (FDA) · 5600 Fishers Lane · Rockville MD 20857 · 800-439-1420